nodes	percent_of_prediction	percent_of_DWPC	metapath
Desvenlafaxine—SLC6A4—chronic obstructive pulmonary disease	0.637	1	CbGaD
Desvenlafaxine—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.0575	0.282	CbGbCtD
Desvenlafaxine—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.0389	0.19	CbGbCtD
Desvenlafaxine—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.0371	0.182	CbGbCtD
Desvenlafaxine—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.0331	0.162	CbGbCtD
Desvenlafaxine—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.0194	0.0949	CbGbCtD
Desvenlafaxine—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.0183	0.0897	CbGbCtD
Desvenlafaxine—Venlafaxine—SLC6A4—chronic obstructive pulmonary disease	0.00208	1	CrCbGaD
Desvenlafaxine—CYP3A4—Lidocaine metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000614	0.0905	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Aflatoxin B1 metabolism—EPHX1—chronic obstructive pulmonary disease	0.000543	0.08	CbGpPWpGaD
Desvenlafaxine—Angioedema—Tiotropium—chronic obstructive pulmonary disease	0.000523	0.00349	CcSEcCtD
Desvenlafaxine—Connective tissue disorder—Arformoterol—chronic obstructive pulmonary disease	0.000522	0.00348	CcSEcCtD
Desvenlafaxine—Connective tissue disorder—Formoterol—chronic obstructive pulmonary disease	0.000522	0.00348	CcSEcCtD
Desvenlafaxine—Urethral disorder—Formoterol—chronic obstructive pulmonary disease	0.000521	0.00347	CcSEcCtD
Desvenlafaxine—Urethral disorder—Arformoterol—chronic obstructive pulmonary disease	0.000521	0.00347	CcSEcCtD
Desvenlafaxine—Hallucination—Montelukast—chronic obstructive pulmonary disease	0.000518	0.00345	CcSEcCtD
Desvenlafaxine—Anxiety—Aminophylline—chronic obstructive pulmonary disease	0.000515	0.00344	CcSEcCtD
Desvenlafaxine—Syncope—Tiotropium—chronic obstructive pulmonary disease	0.000514	0.00343	CcSEcCtD
Desvenlafaxine—Urinary tract disorder—Montelukast—chronic obstructive pulmonary disease	0.000514	0.00343	CcSEcCtD
Desvenlafaxine—Connective tissue disorder—Montelukast—chronic obstructive pulmonary disease	0.000511	0.00341	CcSEcCtD
Desvenlafaxine—Urethral disorder—Montelukast—chronic obstructive pulmonary disease	0.00051	0.0034	CcSEcCtD
Desvenlafaxine—Diarrhoea—Roflumilast—chronic obstructive pulmonary disease	0.000509	0.00339	CcSEcCtD
Desvenlafaxine—Palpitations—Tiotropium—chronic obstructive pulmonary disease	0.000506	0.00338	CcSEcCtD
Desvenlafaxine—Loss of consciousness—Tiotropium—chronic obstructive pulmonary disease	0.000503	0.00336	CcSEcCtD
Desvenlafaxine—Urinary tract disorder—Salbutamol—chronic obstructive pulmonary disease	0.000495	0.0033	CcSEcCtD
Desvenlafaxine—Hypertension—Tiotropium—chronic obstructive pulmonary disease	0.000495	0.0033	CcSEcCtD
Desvenlafaxine—Cardiac disorder—Arformoterol—chronic obstructive pulmonary disease	0.000493	0.00329	CcSEcCtD
Desvenlafaxine—Cardiac disorder—Formoterol—chronic obstructive pulmonary disease	0.000493	0.00329	CcSEcCtD
Desvenlafaxine—Connective tissue disorder—Salbutamol—chronic obstructive pulmonary disease	0.000493	0.00329	CcSEcCtD
Desvenlafaxine—Erythema multiforme—Montelukast—chronic obstructive pulmonary disease	0.000492	0.00328	CcSEcCtD
Desvenlafaxine—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.000492	0.00328	CcSEcCtD
Desvenlafaxine—Urethral disorder—Salbutamol—chronic obstructive pulmonary disease	0.000492	0.00328	CcSEcCtD
Desvenlafaxine—Shock—Aminophylline—chronic obstructive pulmonary disease	0.000488	0.00325	CcSEcCtD
Desvenlafaxine—Nervous system disorder—Aminophylline—chronic obstructive pulmonary disease	0.000486	0.00324	CcSEcCtD
Desvenlafaxine—Unspecified disorder of skin and subcutaneous tissue—Tiotropium—chronic obstructive pulmonary disease	0.000484	0.00323	CcSEcCtD
Desvenlafaxine—Tachycardia—Aminophylline—chronic obstructive pulmonary disease	0.000484	0.00323	CcSEcCtD
Desvenlafaxine—Cardiac disorder—Montelukast—chronic obstructive pulmonary disease	0.000483	0.00322	CcSEcCtD
Desvenlafaxine—Immune system disorder—Arformoterol—chronic obstructive pulmonary disease	0.00048	0.0032	CcSEcCtD
Desvenlafaxine—Immune system disorder—Formoterol—chronic obstructive pulmonary disease	0.00048	0.0032	CcSEcCtD
Desvenlafaxine—Mediastinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000479	0.00319	CcSEcCtD
Desvenlafaxine—Mediastinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000479	0.00319	CcSEcCtD
Desvenlafaxine—Dry mouth—Tiotropium—chronic obstructive pulmonary disease	0.000477	0.00318	CcSEcCtD
Desvenlafaxine—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.000473	0.00315	CcSEcCtD
Desvenlafaxine—Immune system disorder—Montelukast—chronic obstructive pulmonary disease	0.00047	0.00313	CcSEcCtD
Desvenlafaxine—Mediastinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000469	0.00313	CcSEcCtD
Desvenlafaxine—Rash—Roflumilast—chronic obstructive pulmonary disease	0.000469	0.00313	CcSEcCtD
Desvenlafaxine—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.000468	0.00312	CcSEcCtD
Desvenlafaxine—Tinnitus—Salbutamol—chronic obstructive pulmonary disease	0.000468	0.00312	CcSEcCtD
Desvenlafaxine—Headache—Roflumilast—chronic obstructive pulmonary disease	0.000466	0.00311	CcSEcCtD
Desvenlafaxine—Cardiac disorder—Salbutamol—chronic obstructive pulmonary disease	0.000465	0.0031	CcSEcCtD
Desvenlafaxine—Mental disorder—Arformoterol—chronic obstructive pulmonary disease	0.000465	0.0031	CcSEcCtD
Desvenlafaxine—Mental disorder—Formoterol—chronic obstructive pulmonary disease	0.000465	0.0031	CcSEcCtD
Desvenlafaxine—Malnutrition—Formoterol—chronic obstructive pulmonary disease	0.000462	0.00308	CcSEcCtD
Desvenlafaxine—Malnutrition—Arformoterol—chronic obstructive pulmonary disease	0.000462	0.00308	CcSEcCtD
Desvenlafaxine—Shock—Tiotropium—chronic obstructive pulmonary disease	0.00046	0.00307	CcSEcCtD
Desvenlafaxine—Nervous system disorder—Tiotropium—chronic obstructive pulmonary disease	0.000458	0.00306	CcSEcCtD
Desvenlafaxine—Tachycardia—Tiotropium—chronic obstructive pulmonary disease	0.000456	0.00304	CcSEcCtD
Desvenlafaxine—Mental disorder—Montelukast—chronic obstructive pulmonary disease	0.000456	0.00304	CcSEcCtD
Desvenlafaxine—Angiopathy—Salbutamol—chronic obstructive pulmonary disease	0.000455	0.00303	CcSEcCtD
Desvenlafaxine—Skin disorder—Tiotropium—chronic obstructive pulmonary disease	0.000454	0.00303	CcSEcCtD
Desvenlafaxine—Tension—Arformoterol—chronic obstructive pulmonary disease	0.000454	0.00303	CcSEcCtD
Desvenlafaxine—Tension—Formoterol—chronic obstructive pulmonary disease	0.000454	0.00303	CcSEcCtD
Desvenlafaxine—Immune system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000453	0.00302	CcSEcCtD
Desvenlafaxine—Dysgeusia—Arformoterol—chronic obstructive pulmonary disease	0.000453	0.00302	CcSEcCtD
Desvenlafaxine—Dysgeusia—Formoterol—chronic obstructive pulmonary disease	0.000453	0.00302	CcSEcCtD
Desvenlafaxine—Mediastinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000452	0.00301	CcSEcCtD
Desvenlafaxine—Chills—Salbutamol—chronic obstructive pulmonary disease	0.00045	0.003	CcSEcCtD
Desvenlafaxine—Nervousness—Formoterol—chronic obstructive pulmonary disease	0.000449	0.00299	CcSEcCtD
Desvenlafaxine—Nervousness—Arformoterol—chronic obstructive pulmonary disease	0.000449	0.00299	CcSEcCtD
Desvenlafaxine—Insomnia—Aminophylline—chronic obstructive pulmonary disease	0.000448	0.00299	CcSEcCtD
Desvenlafaxine—CYP3A4—Benzo(a)pyrene metabolism—EPHX1—chronic obstructive pulmonary disease	0.000444	0.0655	CbGpPWpGaD
Desvenlafaxine—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.000442	0.00294	CcSEcCtD
Desvenlafaxine—Mental disorder—Salbutamol—chronic obstructive pulmonary disease	0.000439	0.00293	CcSEcCtD
Desvenlafaxine—Malnutrition—Salbutamol—chronic obstructive pulmonary disease	0.000437	0.00291	CcSEcCtD
Desvenlafaxine—Tremor—Formoterol—chronic obstructive pulmonary disease	0.000433	0.00289	CcSEcCtD
Desvenlafaxine—Tremor—Arformoterol—chronic obstructive pulmonary disease	0.000433	0.00289	CcSEcCtD
Desvenlafaxine—Decreased appetite—Aminophylline—chronic obstructive pulmonary disease	0.000431	0.00287	CcSEcCtD
Desvenlafaxine—Tension—Salbutamol—chronic obstructive pulmonary disease	0.000428	0.00286	CcSEcCtD
Desvenlafaxine—Dysgeusia—Salbutamol—chronic obstructive pulmonary disease	0.000427	0.00285	CcSEcCtD
Desvenlafaxine—Tremor—Montelukast—chronic obstructive pulmonary disease	0.000424	0.00283	CcSEcCtD
Desvenlafaxine—Nervousness—Salbutamol—chronic obstructive pulmonary disease	0.000424	0.00283	CcSEcCtD
Desvenlafaxine—Insomnia—Tiotropium—chronic obstructive pulmonary disease	0.000423	0.00282	CcSEcCtD
Desvenlafaxine—Angioedema—Arformoterol—chronic obstructive pulmonary disease	0.000422	0.00282	CcSEcCtD
Desvenlafaxine—Angioedema—Formoterol—chronic obstructive pulmonary disease	0.000422	0.00282	CcSEcCtD
Desvenlafaxine—Paraesthesia—Tiotropium—chronic obstructive pulmonary disease	0.00042	0.0028	CcSEcCtD
Desvenlafaxine—Angioedema—Montelukast—chronic obstructive pulmonary disease	0.000414	0.00276	CcSEcCtD
Desvenlafaxine—Tremor—Salbutamol—chronic obstructive pulmonary disease	0.000409	0.00273	CcSEcCtD
Desvenlafaxine—Palpitations—Arformoterol—chronic obstructive pulmonary disease	0.000409	0.00272	CcSEcCtD
Desvenlafaxine—Palpitations—Formoterol—chronic obstructive pulmonary disease	0.000409	0.00272	CcSEcCtD
Desvenlafaxine—Gastrointestinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.000404	0.00269	CcSEcCtD
Desvenlafaxine—Palpitations—Montelukast—chronic obstructive pulmonary disease	0.0004	0.00267	CcSEcCtD
Desvenlafaxine—Constipation—Tiotropium—chronic obstructive pulmonary disease	0.0004	0.00267	CcSEcCtD
Desvenlafaxine—Hypertension—Formoterol—chronic obstructive pulmonary disease	0.000399	0.00266	CcSEcCtD
Desvenlafaxine—Hypertension—Arformoterol—chronic obstructive pulmonary disease	0.000399	0.00266	CcSEcCtD
Desvenlafaxine—Angioedema—Salbutamol—chronic obstructive pulmonary disease	0.000399	0.00266	CcSEcCtD
Desvenlafaxine—Convulsion—Montelukast—chronic obstructive pulmonary disease	0.000392	0.00262	CcSEcCtD
Desvenlafaxine—Anxiety—Formoterol—chronic obstructive pulmonary disease	0.000392	0.00262	CcSEcCtD
Desvenlafaxine—Anxiety—Arformoterol—chronic obstructive pulmonary disease	0.000392	0.00262	CcSEcCtD
Desvenlafaxine—Vertigo—Salbutamol—chronic obstructive pulmonary disease	0.000392	0.00262	CcSEcCtD
Desvenlafaxine—Syncope—Salbutamol—chronic obstructive pulmonary disease	0.000391	0.00261	CcSEcCtD
Desvenlafaxine—Unspecified disorder of skin and subcutaneous tissue—Formoterol—chronic obstructive pulmonary disease	0.000391	0.00261	CcSEcCtD
Desvenlafaxine—Unspecified disorder of skin and subcutaneous tissue—Arformoterol—chronic obstructive pulmonary disease	0.000391	0.00261	CcSEcCtD
Desvenlafaxine—Palpitations—Salbutamol—chronic obstructive pulmonary disease	0.000386	0.00257	CcSEcCtD
Desvenlafaxine—Dry mouth—Formoterol—chronic obstructive pulmonary disease	0.000385	0.00257	CcSEcCtD
Desvenlafaxine—Dry mouth—Arformoterol—chronic obstructive pulmonary disease	0.000385	0.00257	CcSEcCtD
Desvenlafaxine—Anxiety—Montelukast—chronic obstructive pulmonary disease	0.000384	0.00256	CcSEcCtD
Desvenlafaxine—Loss of consciousness—Salbutamol—chronic obstructive pulmonary disease	0.000384	0.00256	CcSEcCtD
Desvenlafaxine—Unspecified disorder of skin and subcutaneous tissue—Montelukast—chronic obstructive pulmonary disease	0.000383	0.00255	CcSEcCtD
Desvenlafaxine—Hypertension—Salbutamol—chronic obstructive pulmonary disease	0.000377	0.00251	CcSEcCtD
Desvenlafaxine—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.00037	0.00247	CcSEcCtD
Desvenlafaxine—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.00037	0.00247	CcSEcCtD
Desvenlafaxine—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.00037	0.00247	CcSEcCtD
Desvenlafaxine—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.000368	0.00246	CcSEcCtD
Desvenlafaxine—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.000368	0.00246	CcSEcCtD
Desvenlafaxine—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.000366	0.00244	CcSEcCtD
Desvenlafaxine—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.000366	0.00244	CcSEcCtD
Desvenlafaxine—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000365	0.00244	CcSEcCtD
Desvenlafaxine—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.000363	0.00242	CcSEcCtD
Desvenlafaxine—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.000362	0.00242	CcSEcCtD
Desvenlafaxine—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.000359	0.00239	CcSEcCtD
Desvenlafaxine—Shock—Salbutamol—chronic obstructive pulmonary disease	0.00035	0.00234	CcSEcCtD
Desvenlafaxine—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000349	0.00233	CcSEcCtD
Desvenlafaxine—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.000348	0.00232	CcSEcCtD
Desvenlafaxine—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.000346	0.00231	CcSEcCtD
Desvenlafaxine—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000344	0.0023	CcSEcCtD
Desvenlafaxine—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.000344	0.0023	CcSEcCtD
Desvenlafaxine—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000341	0.00228	CcSEcCtD
Desvenlafaxine—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000341	0.00228	CcSEcCtD
Desvenlafaxine—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000339	0.00226	CcSEcCtD
Desvenlafaxine—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000335	0.00224	CcSEcCtD
Desvenlafaxine—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000335	0.00224	CcSEcCtD
Desvenlafaxine—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000334	0.00223	CcSEcCtD
Desvenlafaxine—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.000332	0.00221	CcSEcCtD
Desvenlafaxine—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000329	0.00219	CcSEcCtD
Desvenlafaxine—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000328	0.00219	CcSEcCtD
Desvenlafaxine—Weight increased—Prednisolone—chronic obstructive pulmonary disease	0.000327	0.00218	CcSEcCtD
Desvenlafaxine—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000326	0.00217	CcSEcCtD
Desvenlafaxine—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000326	0.00217	CcSEcCtD
Desvenlafaxine—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000325	0.00217	CcSEcCtD
Desvenlafaxine—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000325	0.00217	CcSEcCtD
Desvenlafaxine—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000323	0.00215	CcSEcCtD
Desvenlafaxine—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000323	0.00215	CcSEcCtD
Desvenlafaxine—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000322	0.00215	CcSEcCtD
Desvenlafaxine—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.00032	0.00213	CcSEcCtD
Desvenlafaxine—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000319	0.00213	CcSEcCtD
Desvenlafaxine—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000319	0.00212	CcSEcCtD
Desvenlafaxine—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000317	0.00211	CcSEcCtD
Desvenlafaxine—Acute coronary syndrome—Prednisolone—chronic obstructive pulmonary disease	0.000316	0.00211	CcSEcCtD
Desvenlafaxine—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000315	0.0021	CcSEcCtD
Desvenlafaxine—Myocardial infarction—Prednisolone—chronic obstructive pulmonary disease	0.000314	0.00209	CcSEcCtD
Desvenlafaxine—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000313	0.00208	CcSEcCtD
Desvenlafaxine—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000312	0.00208	CcSEcCtD
Desvenlafaxine—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000311	0.00207	CcSEcCtD
Desvenlafaxine—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.00031	0.00207	CcSEcCtD
Desvenlafaxine—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000309	0.00206	CcSEcCtD
Desvenlafaxine—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000308	0.00205	CcSEcCtD
Desvenlafaxine—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000307	0.00205	CcSEcCtD
Desvenlafaxine—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000305	0.00203	CcSEcCtD
Desvenlafaxine—Gastrointestinal haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.000302	0.00201	CcSEcCtD
Desvenlafaxine—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000297	0.00198	CcSEcCtD
Desvenlafaxine—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000295	0.00197	CcSEcCtD
Desvenlafaxine—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000294	0.00196	CcSEcCtD
Desvenlafaxine—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000294	0.00196	CcSEcCtD
Desvenlafaxine—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000293	0.00195	CcSEcCtD
Desvenlafaxine—Irritability—Prednisone—chronic obstructive pulmonary disease	0.000288	0.00192	CcSEcCtD
Desvenlafaxine—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000278	0.00185	CcSEcCtD
Desvenlafaxine—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000278	0.00185	CcSEcCtD
Desvenlafaxine—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000278	0.00185	CcSEcCtD
Desvenlafaxine—SLC6A2—Monoamine Transport—SLC6A4—chronic obstructive pulmonary disease	0.000272	0.0402	CbGpPWpGaD
Desvenlafaxine—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000272	0.00182	CcSEcCtD
Desvenlafaxine—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000271	0.00181	CcSEcCtD
Desvenlafaxine—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000271	0.00181	CcSEcCtD
Desvenlafaxine—SLC6A4—Serotonin Transporter Activity—IL1B—chronic obstructive pulmonary disease	0.000271	0.0399	CbGpPWpGaD
Desvenlafaxine—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000265	0.00177	CcSEcCtD
Desvenlafaxine—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000262	0.00175	CcSEcCtD
Desvenlafaxine—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000258	0.00172	CcSEcCtD
Desvenlafaxine—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000258	0.00172	CcSEcCtD
Desvenlafaxine—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000256	0.0017	CcSEcCtD
Desvenlafaxine—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000253	0.00169	CcSEcCtD
Desvenlafaxine—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000249	0.00166	CcSEcCtD
Desvenlafaxine—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000249	0.00166	CcSEcCtD
Desvenlafaxine—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000244	0.00163	CcSEcCtD
Desvenlafaxine—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000244	0.00163	CcSEcCtD
Desvenlafaxine—Erectile dysfunction—Prednisone—chronic obstructive pulmonary disease	0.00024	0.0016	CcSEcCtD
Desvenlafaxine—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.00024	0.0016	CcSEcCtD
Desvenlafaxine—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.00024	0.0016	CcSEcCtD
Desvenlafaxine—Rash—Formoterol—chronic obstructive pulmonary disease	0.000238	0.00159	CcSEcCtD
Desvenlafaxine—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000238	0.00159	CcSEcCtD
Desvenlafaxine—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000238	0.00158	CcSEcCtD
Desvenlafaxine—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000238	0.00158	CcSEcCtD
Desvenlafaxine—Weight increased—Prednisone—chronic obstructive pulmonary disease	0.000238	0.00158	CcSEcCtD
Desvenlafaxine—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000236	0.00158	CcSEcCtD
Desvenlafaxine—Headache—Formoterol—chronic obstructive pulmonary disease	0.000236	0.00158	CcSEcCtD
Desvenlafaxine—Weight decreased—Prednisone—chronic obstructive pulmonary disease	0.000236	0.00158	CcSEcCtD
Desvenlafaxine—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	0.000236	0.00157	CcSEcCtD
Desvenlafaxine—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000236	0.00157	CcSEcCtD
Desvenlafaxine—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000235	0.00157	CcSEcCtD
Desvenlafaxine—Rash—Montelukast—chronic obstructive pulmonary disease	0.000233	0.00155	CcSEcCtD
Desvenlafaxine—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000233	0.00155	CcSEcCtD
Desvenlafaxine—Headache—Montelukast—chronic obstructive pulmonary disease	0.000232	0.00154	CcSEcCtD
Desvenlafaxine—Acute coronary syndrome—Prednisone—chronic obstructive pulmonary disease	0.000229	0.00153	CcSEcCtD
Desvenlafaxine—Angioedema—Prednisolone—chronic obstructive pulmonary disease	0.000229	0.00153	CcSEcCtD
Desvenlafaxine—Myocardial infarction—Prednisone—chronic obstructive pulmonary disease	0.000228	0.00152	CcSEcCtD
Desvenlafaxine—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000227	0.00151	CcSEcCtD
Desvenlafaxine—CYP3A4—Aflatoxin B1 metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000226	0.0332	CbGpPWpGaD
Desvenlafaxine—Vertigo—Prednisolone—chronic obstructive pulmonary disease	0.000225	0.0015	CcSEcCtD
Desvenlafaxine—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000225	0.0015	CcSEcCtD
Desvenlafaxine—Syncope—Prednisolone—chronic obstructive pulmonary disease	0.000225	0.0015	CcSEcCtD
Desvenlafaxine—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000224	0.0015	CcSEcCtD
Desvenlafaxine—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000224	0.00149	CcSEcCtD
Desvenlafaxine—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000224	0.00149	CcSEcCtD
Desvenlafaxine—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000223	0.00149	CcSEcCtD
Desvenlafaxine—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	0.00022	0.00147	CcSEcCtD
Desvenlafaxine—Nausea—Montelukast—chronic obstructive pulmonary disease	0.00022	0.00146	CcSEcCtD
Desvenlafaxine—Convulsion—Prednisolone—chronic obstructive pulmonary disease	0.000217	0.00145	CcSEcCtD
Desvenlafaxine—Hypertension—Prednisolone—chronic obstructive pulmonary disease	0.000216	0.00144	CcSEcCtD
Desvenlafaxine—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000212	0.00141	CcSEcCtD
Desvenlafaxine—Hallucination—Prednisone—chronic obstructive pulmonary disease	0.000208	0.00139	CcSEcCtD
Desvenlafaxine—Connective tissue disorder—Prednisone—chronic obstructive pulmonary disease	0.000205	0.00137	CcSEcCtD
Desvenlafaxine—Shock—Prednisolone—chronic obstructive pulmonary disease	0.000201	0.00134	CcSEcCtD
Desvenlafaxine—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	0.000199	0.00133	CcSEcCtD
Desvenlafaxine—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	0.000198	0.00132	CcSEcCtD
Desvenlafaxine—Eye disorder—Prednisone—chronic obstructive pulmonary disease	0.000195	0.0013	CcSEcCtD
Desvenlafaxine—Angiopathy—Prednisone—chronic obstructive pulmonary disease	0.00019	0.00126	CcSEcCtD
Desvenlafaxine—Immune system disorder—Prednisone—chronic obstructive pulmonary disease	0.000189	0.00126	CcSEcCtD
Desvenlafaxine—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.000185	0.00123	CcSEcCtD
Desvenlafaxine—Alopecia—Prednisone—chronic obstructive pulmonary disease	0.000185	0.00123	CcSEcCtD
Desvenlafaxine—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.000183	0.00122	CcSEcCtD
Desvenlafaxine—Mental disorder—Prednisone—chronic obstructive pulmonary disease	0.000183	0.00122	CcSEcCtD
Desvenlafaxine—Malnutrition—Prednisone—chronic obstructive pulmonary disease	0.000182	0.00121	CcSEcCtD
Desvenlafaxine—CYP3A4—Aflatoxin B1 metabolism—GSTM1—chronic obstructive pulmonary disease	0.000173	0.0255	CbGpPWpGaD
Desvenlafaxine—Vision blurred—Prednisone—chronic obstructive pulmonary disease	0.000171	0.00114	CcSEcCtD
Desvenlafaxine—Angioedema—Prednisone—chronic obstructive pulmonary disease	0.000166	0.00111	CcSEcCtD
Desvenlafaxine—Vertigo—Prednisone—chronic obstructive pulmonary disease	0.000163	0.00109	CcSEcCtD
Desvenlafaxine—Syncope—Prednisone—chronic obstructive pulmonary disease	0.000163	0.00109	CcSEcCtD
Desvenlafaxine—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	0.00016	0.00107	CcSEcCtD
Desvenlafaxine—Convulsion—Prednisone—chronic obstructive pulmonary disease	0.000158	0.00105	CcSEcCtD
Desvenlafaxine—Hypertension—Prednisone—chronic obstructive pulmonary disease	0.000157	0.00105	CcSEcCtD
Desvenlafaxine—SLC6A4—NRF2 pathway—SOD3—chronic obstructive pulmonary disease	0.000155	0.0229	CbGpPWpGaD
Desvenlafaxine—Anxiety—Prednisone—chronic obstructive pulmonary disease	0.000154	0.00103	CcSEcCtD
Desvenlafaxine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	0.000154	0.00103	CcSEcCtD
Desvenlafaxine—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.000151	0.001	CcSEcCtD
Desvenlafaxine—Shock—Prednisone—chronic obstructive pulmonary disease	0.000146	0.000974	CcSEcCtD
Desvenlafaxine—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	0.000146	0.000971	CcSEcCtD
Desvenlafaxine—Tachycardia—Prednisone—chronic obstructive pulmonary disease	0.000145	0.000966	CcSEcCtD
Desvenlafaxine—Skin disorder—Prednisone—chronic obstructive pulmonary disease	0.000144	0.000962	CcSEcCtD
Desvenlafaxine—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	0.000144	0.000957	CcSEcCtD
Desvenlafaxine—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000135	0.000901	CcSEcCtD
Desvenlafaxine—Insomnia—Prednisone—chronic obstructive pulmonary disease	0.000134	0.000896	CcSEcCtD
Desvenlafaxine—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000134	0.0197	CbGpPWpGaD
Desvenlafaxine—SLC6A2—NRF2 pathway—SOD3—chronic obstructive pulmonary disease	0.000134	0.0197	CbGpPWpGaD
Desvenlafaxine—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	0.000133	0.000889	CcSEcCtD
Desvenlafaxine—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	0.000129	0.000861	CcSEcCtD
Desvenlafaxine—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000129	0.000859	CcSEcCtD
Desvenlafaxine—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000129	0.000858	CcSEcCtD
Desvenlafaxine—Fatigue—Prednisone—chronic obstructive pulmonary disease	0.000128	0.000854	CcSEcCtD
Desvenlafaxine—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000128	0.000854	CcSEcCtD
Desvenlafaxine—Constipation—Prednisone—chronic obstructive pulmonary disease	0.000127	0.000847	CcSEcCtD
Desvenlafaxine—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000121	0.000809	CcSEcCtD
Desvenlafaxine—CYP3A4—Fatty Acid Omega Oxidation—CYP1A2—chronic obstructive pulmonary disease	0.000116	0.0172	CbGpPWpGaD
Desvenlafaxine—SLC6A4—Monoamine Transport—IL1B—chronic obstructive pulmonary disease	0.000115	0.017	CbGpPWpGaD
Desvenlafaxine—SLC6A4—NRF2 pathway—SERPINA1—chronic obstructive pulmonary disease	0.000111	0.0163	CbGpPWpGaD
Desvenlafaxine—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.000109	0.00073	CcSEcCtD
Desvenlafaxine—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.000107	0.00071	CcSEcCtD
Desvenlafaxine—CYP3A4—Estrogen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000106	0.0156	CbGpPWpGaD
Desvenlafaxine—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.000102	0.000677	CcSEcCtD
Desvenlafaxine—CYP3A4—Aflatoxin activation and detoxification—CYP1A2—chronic obstructive pulmonary disease	0.000101	0.0149	CbGpPWpGaD
Desvenlafaxine—SLC6A4—NRF2 pathway—GCLC—chronic obstructive pulmonary disease	0.000101	0.0149	CbGpPWpGaD
Desvenlafaxine—SLC6A2—Monoamine Transport—IL1B—chronic obstructive pulmonary disease	9.91e-05	0.0146	CbGpPWpGaD
Desvenlafaxine—SLC6A4—SIDS Susceptibility Pathways—IL13—chronic obstructive pulmonary disease	9.89e-05	0.0146	CbGpPWpGaD
Desvenlafaxine—SLC6A2—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	9.83e-05	0.0145	CbGpPWpGaD
Desvenlafaxine—Dizziness—Prednisone—chronic obstructive pulmonary disease	9.82e-05	0.000655	CcSEcCtD
Desvenlafaxine—CYP3A4—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	9.74e-05	0.0143	CbGpPWpGaD
Desvenlafaxine—SLC6A4—NRF2 pathway—TGFB2—chronic obstructive pulmonary disease	9.59e-05	0.0141	CbGpPWpGaD
Desvenlafaxine—SLC6A2—NRF2 pathway—SERPINA1—chronic obstructive pulmonary disease	9.52e-05	0.014	CbGpPWpGaD
Desvenlafaxine—Vomiting—Prednisone—chronic obstructive pulmonary disease	9.44e-05	0.00063	CcSEcCtD
Desvenlafaxine—CYP3A4—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	9.36e-05	0.0138	CbGpPWpGaD
Desvenlafaxine—Rash—Prednisone—chronic obstructive pulmonary disease	9.36e-05	0.000624	CcSEcCtD
Desvenlafaxine—Dermatitis—Prednisone—chronic obstructive pulmonary disease	9.35e-05	0.000624	CcSEcCtD
Desvenlafaxine—Headache—Prednisone—chronic obstructive pulmonary disease	9.3e-05	0.00062	CcSEcCtD
Desvenlafaxine—Nausea—Prednisone—chronic obstructive pulmonary disease	8.82e-05	0.000588	CcSEcCtD
Desvenlafaxine—SLC6A2—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	8.76e-05	0.0129	CbGpPWpGaD
Desvenlafaxine—SLC6A2—NRF2 pathway—GCLC—chronic obstructive pulmonary disease	8.7e-05	0.0128	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—chronic obstructive pulmonary disease	8.46e-05	0.0125	CbGpPWpGaD
Desvenlafaxine—SLC6A4—Monoamine Transport—TNF—chronic obstructive pulmonary disease	8.36e-05	0.0123	CbGpPWpGaD
Desvenlafaxine—SLC6A2—NRF2 pathway—TGFB2—chronic obstructive pulmonary disease	8.25e-05	0.0122	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Estrogen metabolism—GSTM1—chronic obstructive pulmonary disease	8.12e-05	0.012	CbGpPWpGaD
Desvenlafaxine—SLC6A2—NRF2 pathway—SLC6A4—chronic obstructive pulmonary disease	8.09e-05	0.0119	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Estrogen metabolism—CYP1A1—chronic obstructive pulmonary disease	7.7e-05	0.0113	CbGpPWpGaD
Desvenlafaxine—SLC6A2—Monoamine Transport—TNF—chronic obstructive pulmonary disease	7.19e-05	0.0106	CbGpPWpGaD
Desvenlafaxine—SLC6A4—NRF2 pathway—GSTP1—chronic obstructive pulmonary disease	7.1e-05	0.0105	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	7.07e-05	0.0104	CbGpPWpGaD
Desvenlafaxine—SLC6A4—NRF2 pathway—HMOX1—chronic obstructive pulmonary disease	7e-05	0.0103	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	6.8e-05	0.01	CbGpPWpGaD
Desvenlafaxine—SLC6A4—Circadian rythm related genes—ADIPOQ—chronic obstructive pulmonary disease	6.69e-05	0.00986	CbGpPWpGaD
Desvenlafaxine—SLC6A4—Circadian rythm related genes—HDAC2—chronic obstructive pulmonary disease	6.66e-05	0.00982	CbGpPWpGaD
Desvenlafaxine—SLC6A4—NRF2 pathway—GSTM1—chronic obstructive pulmonary disease	6.52e-05	0.00961	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	6.37e-05	0.00939	CbGpPWpGaD
Desvenlafaxine—SLC6A4—SIDS Susceptibility Pathways—IL10—chronic obstructive pulmonary disease	6.18e-05	0.00911	CbGpPWpGaD
Desvenlafaxine—SLC6A2—NRF2 pathway—GSTP1—chronic obstructive pulmonary disease	6.1e-05	0.00899	CbGpPWpGaD
Desvenlafaxine—SLC6A2—NRF2 pathway—HMOX1—chronic obstructive pulmonary disease	6.02e-05	0.00887	CbGpPWpGaD
Desvenlafaxine—SLC6A2—NRF2 pathway—GSTM1—chronic obstructive pulmonary disease	5.61e-05	0.00826	CbGpPWpGaD
Desvenlafaxine—SLC6A4—SIDS Susceptibility Pathways—HTR2A—chronic obstructive pulmonary disease	5.47e-05	0.00807	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Tryptophan metabolism—CYP1A2—chronic obstructive pulmonary disease	5e-05	0.00737	CbGpPWpGaD
Desvenlafaxine—SLC6A4—Circadian rythm related genes—LEP—chronic obstructive pulmonary disease	4.15e-05	0.00612	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	4.14e-05	0.00609	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	4.04e-05	0.00596	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	3.99e-05	0.00588	CbGpPWpGaD
Desvenlafaxine—SLC6A4—Circadian rythm related genes—NOS2—chronic obstructive pulmonary disease	3.87e-05	0.00571	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	3.63e-05	0.00535	CbGpPWpGaD
Desvenlafaxine—SLC6A4—SIDS Susceptibility Pathways—CXCL8—chronic obstructive pulmonary disease	3.38e-05	0.00498	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	3.28e-05	0.00483	CbGpPWpGaD
Desvenlafaxine—SLC6A4—Circadian rythm related genes—SERPINE1—chronic obstructive pulmonary disease	3.26e-05	0.0048	CbGpPWpGaD
Desvenlafaxine—SLC6A4—SIDS Susceptibility Pathways—IL1B—chronic obstructive pulmonary disease	3.24e-05	0.00478	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	2.94e-05	0.00433	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	2.9e-05	0.00427	CbGpPWpGaD
Desvenlafaxine—SLC6A4—SIDS Susceptibility Pathways—VEGFA—chronic obstructive pulmonary disease	2.75e-05	0.00405	CbGpPWpGaD
Desvenlafaxine—SLC6A4—NRF2 pathway—TGFB1—chronic obstructive pulmonary disease	2.66e-05	0.00392	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	2.38e-05	0.00351	CbGpPWpGaD
Desvenlafaxine—SLC6A4—SIDS Susceptibility Pathways—TNF—chronic obstructive pulmonary disease	2.35e-05	0.00347	CbGpPWpGaD
Desvenlafaxine—SLC6A2—NRF2 pathway—TGFB1—chronic obstructive pulmonary disease	2.29e-05	0.00337	CbGpPWpGaD
Desvenlafaxine—SLC6A2—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	2.28e-05	0.00336	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	2.1e-05	0.00309	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	2.07e-05	0.00305	CbGpPWpGaD
Desvenlafaxine—SLC6A2—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	1.93e-05	0.00284	CbGpPWpGaD
Desvenlafaxine—SLC6A4—SIDS Susceptibility Pathways—IL6—chronic obstructive pulmonary disease	1.9e-05	0.0028	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	1.74e-05	0.00257	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	1.72e-05	0.00253	CbGpPWpGaD
Desvenlafaxine—SLC6A4—Circadian rythm related genes—TP53—chronic obstructive pulmonary disease	1.69e-05	0.0025	CbGpPWpGaD
Desvenlafaxine—SLC6A4—Circadian rythm related genes—IL6—chronic obstructive pulmonary disease	1.55e-05	0.00229	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	1.45e-05	0.00214	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	1.43e-05	0.00211	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	1.33e-05	0.00197	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	1.32e-05	0.00194	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	1.27e-05	0.00186	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	1.25e-05	0.00184	CbGpPWpGaD
Desvenlafaxine—SLC6A2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	1.16e-05	0.00171	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	1.02e-05	0.0015	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	6.74e-06	0.000993	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	6.56e-06	0.000966	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	6.1e-06	0.000898	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	3.58e-06	0.000528	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	3.54e-06	0.000522	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	3.23e-06	0.000476	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.98e-06	0.000439	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.48e-06	0.000366	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.45e-06	0.000361	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.28e-06	0.000336	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.16e-06	0.000319	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	1.47e-06	0.000217	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	1.41e-06	0.000207	CbGpPWpGaD
